Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-28T03:35:15.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Imipramine and Amitriptyline Plasma Concentrations and Clinical Response in Major Depression

Published online by Cambridge University Press:  29 January 2018

James H. Kocsis ,
Israel Hanin ,
Charles Bowden  and
David Brunswick
James H. Kocsis*
Affiliation:
Cornell Univesity Medical College, Payne Whitney Clinic, The New York Hospital, 525 East 68th Street, New York, NY 10021, USA
Israel Hanin
Affiliation:
Pharmacology and Psychiatry, Western Psychiatric Institute and Clinic, 3811 O'Hara Street, Room 1320, Pittsburgh, Pennsylvania
Charles Bowden
Affiliation:
Department of Psychiatry University of Texas Health Sciences Center, 7703, Floyd Curl Drive, San Antonio, Texas 78284
David Brunswick
Affiliation:
Department of Psychiatry, V. A. Medical Center, University and Woodland Avenues, Philadelphia, Pennsylvania 19104
*
Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Plasma drug concentrations and clinical response were measured in two groups of hospitalised depressed patients, who received amitriptyline or Imipramine double-blind, in a dosage of 250 mg for four weeks. Virtually no significant linear or curvilinear relationships were found between any plasma measure and any measure of clinical response. Modest but significant direct relationships were found between age and concentration of parent drugs but not demethylated metabolites. Blood drug level measurement therefore appears to be of little value in monitoring drug treatment of depressed in-patients.

Type
Papers
Information
The British Journal of Psychiatry , Volume 148 , Issue 1 , January 1986 , pp. 52 - 57
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Åsberg, M. (1974) Individualization of treatment with tricyclic compounds. Medical Clinics of North America, 58, 1083–1091.Google Scholar
Åsberg, M., Cromholm, B., Sjoqvist, F. & Tuck, D. (1971) Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, 3, 331–334.Google Scholar
Bech, P. (1981) Rating scales for affective disorders. Acta Psychiatrica Scandinavica, 64 (Suppl 295), 11–101.Google Scholar
Biggs, J. T., Holland, W. H., Chang, S., Hipps, P. P. & Sherman, W. R. (1976) The electron beam ionization mass fragmentographic analysis of tricyclic antidepressants in human plasma. Journal of Pharmaceutical Science, 65, 261–268.Google Scholar
Braithwaite, R. A., Coulding, R., Theano, G., Bailey, J. & Coppen, A. (1972) Plasma concentration of amitriptyline and clinical response. Lancet, i, 1297–1300.Google Scholar
Breyer, U., Gaertner, H. J., Kreuter, F., Scharek, G., Brinkschulte, M. & Wiatr, R. (1982) Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline levels. Psychopharmacology, 76, 240–244.CrossRefGoogle Scholar
Brunswick, D. J. & Mendels, J. (1977) Reduced levels of tricyclic antidepressants in plasma from vacutainers. Communications in Psychopharmacology, 1, 131–134.Google Scholar
Burrow, C. D. (1977) Plasma levels of tricyclics, clinical response and drug interactions In Handbook of Studies on Depression. (ed. Burrows, C. D.). Amsterdam: Excerpta Medica.Google Scholar
Cochran, E., Carl, J., Hanin, I., Koslow, S. & Robins, E. (1978) Effect of vacutainer stoppers on plasma tricyclic levels: a reevaluation. Communications in Psychopharmacoloty, 2, 495–503.Google Scholar
Cole, J. O. & Davis, J. M. (1975) Antidepressant drugs In Comprehensive Textbook of Psychiatry/II, (eds. Freedman, A. M., Kaplan, H. I. & Sadock, B. J.) Baltimore: Williams and Wilkins.Google Scholar
Coppen, A., Montgomery, S., Chose, K., Rao, V. A. R., Bailey, J., Christiansen, J., Mikkleson, P. L., Van Praag, H. M., Van De Poel, F., Minsker, E. J., Kozuua, V. G., Matussek, N., Junckunz, G. & Jorgensen, A. (1978) Amitriptyline plasma concentration and clinical effect. Lancet, 1, 63–69.Google Scholar
Friedel, R. O.: The relationship of therapeutic response to antidepressant plasma levels: An update. Journal of Clinical Psychopharmacology, 43, 11 (Sec 2) 37, 1982.Google Scholar
Classman, A. H. & Perel, J. M. (1973) The clinical pharmacology of Imipramine. Archives of General Psychiatry, 28, 649–653.Google Scholar
Classman, A. H., Perel, J. M., Shostak, M., Kantor, S. J. & Fleiss, J. L. (1977) Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry. 34, 197–204.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 562.CrossRefGoogle ScholarPubMed
Jungkunz, G. & Kuss, H. J. (1978) Amitryptyline and its demethylation rate. Lancet, 2, 1263–1264.CrossRefGoogle Scholar
Katz, M. M., Koslow, S. H., Berman, N., Secunda, S., Maas, J. W., Casper, R., Kocsis, J. & Stokes, P. (1984) Measures of behavioral and affect states for clinical and psychobiological research. Psychological Reports, 55, 619–671.Google Scholar
Kupfer, D. J., Hanin, I., Spiker, D. G., Grau, T. & Coble, P. (1977) Amitriptyline plasma levels and clinical response in primary depression. Clinical Pharmacology and Therapeutics, 22, 904–911.CrossRefGoogle ScholarPubMed
Liisberg, P., Mose, H., Amidsen, A., Jorgensen, A. & Petersen, H. E. H. (1978) A clinical trial comparing sustained release amitriptyline and conventional amitriptyline tablets in endogenousty depressed patients with simultaneous determination of serum levels of amitriptyline and nortriptyline. Acta Psychiatrica Scandinavica, 57, 426–435.Google Scholar
Maas, J. W., Koslow, S. H., Davis, J. M., Katz, M. M., Mendels, J., Robins, E., Stokes, P. E. & Bowden, C. L. (1980) Biological Component of the NIMH-CRB Collaborative Program on the Psychobiology of Depression I. Psychological Medicine, 10, 759–775.Google Scholar
Mendelwicz, J., Linkowsky, P. & Rees, J. A. (1980) A double blind comparison of dothiepin and amitriptyline in patients with primary affective disorders: Serum levels and clinical response. British Journal of Psychiatry, 136, 154–160.CrossRefGoogle Scholar
Montgomery, S. & Braithwaite, R. (1975) The relationship between plasma concentration of amitriptyline and clinical response. Presented at a meeting of the British Association of Psychopharmocology, London.Google Scholar
Nies, A., Robinson, D. S., Friedman, M. J., Green, R., Cooper, T. B. & Ravaris, C. L. (1977) Relationship between age and tricyclic antidepressant plasma levels. American Journal of Psychiatry, 134, 790–793.Google Scholar
Olivier-Martin, R., Marzin, D., Buschenshutz, E., Pichot, P. & Boissier, J. (1975) Concentrations plasmatiques de l'imipramine et de la desmethylimipramine et effet antidepresseur au cours d'un traitment controle. Psychopharmacologia, 41, 187–195.Google Scholar
Reisby, N., Gram, L. F., Bech, P., Nagy, A., Petersen, G. O., Ortman, J., Ibsen, L, Dencker, S. J., Jacobsen, , Krautwold, O. Sondergaar, I. & Christiansen, J. (1977) Imipramine: Clinical effects and pharmacokinetic variability. Psychopharmacology, 54, 263–272.Google Scholar
Robinson, D. J., Cooper, T. B., Ravaris, C. L., Ives, J. O., Nies, A., Diantha, B. & Lamborn, K. R. (1979) Plasma tricyclic drug levels in amitriptyline-treatcd depressed patients. Psychopharmacology, 63, 223–231.CrossRefGoogle ScholarPubMed
Secunda, S., Koslow, S. H., Redmond, D. E., Garver, D., Ramsey, T. A., Croughan, J., Kocsis, J. H., Hanin, I., Lieberman, K. & Casper, R. (1980) Biological component of the NIMH-CRB collaborative program on the psychobiology of depression II. Psychological Medicine, 10, 777–793.CrossRefGoogle Scholar
Simpson, G. M., White, K. L., Boyd, J. L., Cooper, T. B., Hallaris, A., Wilson, I. C., Raman, E. J. & Ruther, E. Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine. American Journal of Psychiatry (1982) 139, 358–360.Google Scholar
Spitzer, R. L. & Endicott, J. (1973) Schedule of affective disorders and schizophrenia (3rd ed.). Biometrics Research, NY State Psychiatric Institute.Google Scholar
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders. Biometrics Research, NY State Psychiatric Institute, New York.Google Scholar
Ziegler, V. E., Co, B. T., Taylor, J. R., Clayton, P. J. & Biggs, J. T. (1976) Amitriptyline Plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics, 19, 795–801.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.